Deletion of β-arrestin2 alleviates autistic-like behavior caused by dopaminergic system abnormality through an apoptosis pathway in mice

Yu Zhou,Yamei Liu,Qingyu Peng,Feng Li,Fuxue Chen
DOI: https://doi.org/10.1016/j.bbrc.2022.04.024
IF: 3.1
2022-04-01
Biochemical and Biophysical Research Communications
Abstract:Autism is a complex neurodevelopmental disease that may be caused by genetic and environmental factors, that are incompletely understood. Overactivation of dopaminergic receptors can lead to autistic-like behavior. β-arrestin2 (Arrb2) is a scaffolding protein of the arrestin family, which function as cytosolic multifunctional adaptor proteins that activate cell signal transduction and mediate the signal termination and endocytosis of G-protein-coupled receptors (GPCRs) complexes. In this study, we established an Arrb2 knockout (Arrb2 −/− ) mouse to explore the biological function of Arrb2 in autistic-like behavior caused by abnormality in the dopaminergic system. We found that Arrb2 −/− mice did not exhibit the autistic-like behavior normally induced by SKF38393, an agonist of the dopamine receptor 1 (D1R). Compared with wild-type (WT) untreated mice, the SKF38393-treated WT and Arrb2 −/− mice, with or without SKF38393 treatment, showed abnormalities on electroencephalography (EEG). Additionally, compared with the SKF38393-treated WT mice, deficiency of Arrb2 reduced the expression of the apoptotic proteins Bax, CytoC, cleaved-caspase9 and cleaved-caspase3, and increased the expression of the anti-apoptotic protein Bcl-2 after SKF38393 treatment, in hippocampus. These results demonstrated that targeted deletion of Arrb2 impeded the development of autistic-like behavior regulated by dopaminergic system through an anti-apoptotic mechanism.
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?